(Q77214079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

main subject

phase II clinical trial

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

P C Enzinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D H Ilson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

L K Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D P Kelsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1213-1217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

13-cis-retinoic acid in the treatment of oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

The role of polyamines in interferon and retinoic acid mediated synergistic antiproliferative action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Antiproliferative activity of retinoids, interferon α and their combination in five human transformed cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

Oral tegafur and folinic acid for the treatment of advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819990315%2985%3A6%3C1213%3A%3AAID-CNCR1%3E3.0.CO%3B2-N

10.1002/(SICI)1097-0142(19990315)85:6<1213::AID-CNCR1>3.0.CO;2-N

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10189124%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference